EUVIMEDEUVIMED entdecken
Crossref

Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

Akihisa Wada, Tomohiro Enokida, Susumu Okano, Masanobu Sato, Hideki Tanaka, Yuri Ueda, Takao Fujisawa, Naohiro Takeshita, Nobukazu Tanaka, Makoto Tahara

European Journal of Cancer · 2023-05 · 184 · 30-38

DOI: 10.1016/j.ejca.2023.02.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2023-05. Verfasst von Akihisa Wada und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Medical Oncology, National Cancer Centre Hospital East, Kashiwa, Japan; Department of Otorhinolaryngology, Nagoya Univers…. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Anti-Bacterial Agents, Nivolumab, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsAnti-Bacterial AgentsNivolumabAntineoplastic Agents, ImmunologicalImmune Checkpoint InhibitorsSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansMaleFemaleYoung AdultAdultMiddle AgedAgedRecurrenceRetrospective StudiesNeoplasm MetastasisProgression-Free Survival

Stichwörter der Autor:innen

AntibioticsHead and neck cancerImmune checkpoint inhibitorNivolumabPFS2Proton pump inhibitor

Substanzen

Proton Pump InhibitorsAnti-Bacterial AgentsNivolumabAntineoplastic Agents, ImmunologicalImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Head and Neck Medical Oncology, National Cancer Centre Hospital East, Kashiwa, Japan; Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Head and Neck Medical Oncology, National Cancer Centre Hospital East, Kashiwa, Japan.
  • Department of Head and Neck Medical Oncology, National Cancer Centre Hospital East, Kashiwa, Japan. Electronic address: matahara@east.ncc.go.jp.

Zitieren

APA

Wada, A., Enokida, T., Okano, S., Sato, M., Tanaka, H., Ueda, Y., Fujisawa, T., Takeshita, N., Tanaka, N., & Tahara, M. (2023). Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. European Journal of Cancer, 184, 30-38. https://doi.org/10.1016/j.ejca.2023.02.011

Vancouver

Wada A, Enokida T, Okano S, Sato M, Tanaka H, Ueda Y, et al. Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. European Journal of Cancer. 2023;184:30-38. doi:10.1016/j.ejca.2023.02.011

BibTeX
@article{Wada2023,
  author = {Wada, Akihisa and Enokida, Tomohiro and Okano, Susumu and Sato, Masanobu and Tanaka, Hideki and Ueda, Yuri and Fujisawa, Takao and Takeshita, Naohiro and Tanaka, Nobukazu and Tahara, Makoto},
  title = {Proton pump inhibitors and antibiotics adversely effect the efficacy of nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck},
  journal = {European Journal of Cancer},
  year = {2023},
  volume = {184},
  pages = {30--38},
  doi = {10.1016/j.ejca.2023.02.011}
}
Kostenlos starten →